Elite actors and well‑funded startups are turning private epistemic advantages about human ability into marketable technologies and services (embryo selection, private tutoring, gene‑selection analytics). This creates a two‑tier landscape where institutional taboos about innate differences are enforced publicly while wealth buys practical access to enhancement.
— If true, it shifts the debate from abstract equality rhetoric to concrete governance: who can buy biological or educational advantage and how policy should regulate access, advertising, and evidentiary claims.
John Psmith
2026.01.12
100% relevant
The reviewer names venture‑backed embryo‑selection startups, dual‑n‑back cultures, and an elite 'secret' about intelligence that wealthy actors exploit; these concrete actors and commercial pitches anchor the idea.
← Back to All Ideas